Naltrexone for heroin dependence treatment in St. Petersburg, Russia

Journal of Substance Abuse Treatment

Volumn 26, Issue 4, 2004, Pages 285-294

  Krupitsky, Evgeny M ^a   Zvartau, Edwin E ^a   Masalov, Dimitry V ^a   Tsoi, Marina V ^a   Burakov, Andrey M ^a   Egorova, Valentina Y ^a   Didenko, Tatyana Y ^a   Romanova, Tatyana N ^a   Ivanova, Eva B ^a   Bespalov, Anton Y ^a   Verbitskaya, Elena V ^a   Neznanov, Nikolai G ^a   Grinenko, Alexandr Y ^a   O'Brien, Charles P ^b   Woody, George E ^b  

^a PAVLOV FIRST SAINT PETERSBURG STATE MEDICAL UNIVERSITY   (Russian Federation)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Heroin addiction; Naltrexone; Treatment

Indexed keywords

NALTREXONE; PLACEBO;

ABDOMINAL DISCOMFORT; ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DETOXIFICATION; DOUBLE BLIND PROCEDURE; FEMALE; HEROIN DEPENDENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; LONG TERM MEMORY; MALE; NAUSEA; PATIENT COUNSELING; PRIORITY JOURNAL; RASH; RELAPSE; RUSSIAN FEDERATION; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; COMBINED MODALITY THERAPY; DOUBLE-BLIND METHOD; FEMALE; HEROIN DEPENDENCE; HUMANS; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PILOT PROJECTS; PSYCHOTHERAPY; RUSSIA;

EID: 2942624209     PISSN: 07405472     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsat.2004.02.002     Document Type: Article

References (30)

1. American Psychiatric Association Diagnostic and statistical manual of mental disorders. 4th ed. 1994;Author, Washington, DC
2. Anton R.F., Hogan I. Multiple family therapy and naltrexone in the treatment of opiate dependence. Drug and Alcohol Dependence. 8:1981;157-168
3. Beck A.T., Ward C.H., Mendelson M., Mock J., Erbaugh J. An inventory for measuring depression. Archives of General Psychiatry. 4:1961;561-571
4. Callahan E.J., Rawson R.A., McCleave B., Arias R., Glazer M., Liberman R.P. The treatment of heroin addiction: Naltrexone alone and with behavior therapy. International Journal of the Addictions. 15(6):1980;795-807
5. Carroll K.M., Ball S.A., Nick C., O'Connor P.G., Egan D.A., Frankforter T.L., Triffleman E.G., Shi J., Rounsaville B.J. Targeting behavioral therapies to enhance naltrexone treatment of opioid dependence-efficacy of contingency management and significant other involvement. Archives of General Psychiatry. 58(8):2001;755-761
6. Cornish J.W., Metzger D., Woody G.E., Wilson D., McLellan A.T., Vandergrift B., O'Brien C.P. Naltrexone pharmacotherapy for opioid dependent federal probationers. Journal of Substance Abuse Treatment. 14(6):1997;529-534
7. Grabowski J. Effects of contingent payment on compliance with a naltrexone regimen. American Journal of Drug and Alcohol Abuse. 6:1979;355-365
8. Judson B.A., Carney T.M., Goldstein A. Naltrexone treatment of heroin addiction: Efficacy and safety in a double blind dosage comparison. Drug and Alcohol Dependence. 7:1981;325-346
9. Kleber H.D., Kosten T.R. Naltrexone induction: Psychologic and pharmacologic strategies. Journal of Clinical Psychiatry. 45:1984;29-38
10. Kleber H., Kosten T., Gaspari J. Nontolerance to opioid antagonism of naltrexone. Biological Psychiatry. 20:1985;66-72
11. Krupitsky E.M., Burakov A.M., Romanova T.N., Vostrikov V.V., Grinenko A.Y. The syndrome of anhedonia in recently detoxified heroin addicts: assessment and treatment. Abstracts of the International Meeting "Building International Research on Drug Abuse: Global Focus on Youth" 1998;15 National Institute on Drug Abuse, Scottsdale, AZ
12. Krupitsky E.M., Masalov D.V., Didenko T.Y., Burakov A.M., Romanova T.N., Zvartau E.E., Woody G.E. Prevention of suicide by naltrexone in a recently detoxified heroin addict. European Addiction Research. 7:2001;87-88
13. Krupitsky E.M., Burakov A.M., Romanova T.N., Dunaevsky I.V., Strassman R., Grinenko A.Y. Ketamine psychotherapy for heroin addiction: Immediate effects and two-year follow-up. Journal of Substance Abuse Treatment. 23:2002;273-283
14. Krupitsky E.M., Zvartau E.E., Lioznov D.A., Tsoy M.V., Belyaeva T.V., Antonova T.V., Brazhenko N.A., Zagdyn Z.M., Woody G.E. Prevalence of alcoholism and addictions among patients with infectious diseases in St. Petersburg, Russia. Abstract from meeting of College on Problems of Drug Dependence. 2003;89. Bal Harbor, FL
15. McLellan A.T., Luborsky L., Cacciola J., Griffith J. New data from the Addiction Severity Index: Reliability and validity in three centers. Journal of Nervous and Mental Disease. 173:1985;412-423
16. Mercer D., Woody G.E. The Penn-VA Addiction Counseling Manual. 1998;. Available on NIDA web site
17. Meyer R.E., Mirin S.M., Zackow F. Community outcome on narcotic antagonists. Meyer R.E., Mirin S.M. The heroin stimulus. 1979;Plenum Press, New York
18. Monitoring the Future. Trends in Lifetime Prevalence of use of Various Drugs for Eight, Tenth and Twelfth Graders. 1991-2000. 2000;University of Michigan Press, Ann Arbor, MI
19. Navaline H.A., Snider E.C., Petro C., Tobin D., Metzger D., Alterman A., Woody G.E. Preparations for AIDS vaccine trials. An automated version for the Risk Assessment Battery (RAB): Enhancing the assessment of risk behaviors. AIDS Research and Human Retroviruses. 10:1994;281-283
20. Nunes E.V., Quitkin F.M., Donovan S.J., Deliyannides D., Ocepec-Welikson K., Koenig T., Brady R., McGrath P.J., Woody G. Imipramine treatment of opiate dependent patients with depressive disorders. Archives of General Psychiatry. 55:1998;153-160
21. O'Brien C.P., Greenstein R., Mintz J., Woody G.E. Clinical experience with naltrexone. American Journal of Drug and Alcohol Abuse. 2:1975;365-377
22. O'Brien C.P., Childress A.R., McLellan A.T., Ternes J.M., Ehrman R. Use of naltrexone to extinguish opioid conditioned responses. Journal of Clinical Psychiatry. 45:1984;53-56
23. O'Malley S.S., Jaffe A., Chang G., Schottenfeld R.S., Meyer R.E., Rounsaville B.J. Naltrexone and coping skills therapy for alcohol dependence: A controlled study. Archives of General Psychiatry. 49:1992;881-887
24. Overall J.E., Gorham D.R. The Brief Psychiatric Rating Scale. Psychological Reports. 10:1962;799-812
25. Resnick R., Schuyten-Resnick E., Washton A.M. Narcotic antagonists in the treatment of opioid dependence: review and commentary. Comprehensive Psychiatry. 20:1979;116-125
26. Rounsaville B.J. Can psychotherapy rescue naltrexone treatment of opioid addiction? Onken L.S., Blaine J.D., Boren J.J. Integrating behavioral therapies with medications in the treatment of drug dependence. 1995;National Institutes of Health, Rockville, MD. NIDA Research Monograph, Vol. 150, NIH Publication No. 95-3899, pp. 37-52
27. Sideroff S.I., Charuvastra V.C., Jarvik M.E. Craving in heroin addicts maintained on the opiate antagonist naltrexone. American Journal of Drug and Alcohol Abuse. 5:1978;415-423
28. Spielberger C.D., Anton W.D., Bedell J. Zuckerman M., Spielberger C.D. The nature and treatment of test anxiety. Emotion and Anxiety: New concepts, methods and applications. 1976;Erlbaum, Hillsdale, NJ
29. Tennant F.S., Rawson R.A., Cohen A.I., Mann A. Clinical experience with naltrexone in suburban opioid addicts. Journal of Clinical Psychiatry. 45:1984;42-45
30. Washton A.M., Pottash A.C., Gold M.S. Naltrexone in addicted business executives and physicians. Journal of Clinical Psychiatry. 45:1984;39-41